OTC · Biotechnology

Actavia Life Sciences, Inc. (RASP) Stock

$0.00 OTC: RASP Healthcare

Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma.

Valuation

MetricValue
Price$0.00
Market Cap$385906
P/E Ratio-0.06
P/B Ratio-0.15
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE200.00%
ROA—
ROCE216.68%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio0.05

Annual Financials (USD)

Metric20192020202120222023
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-5.0M$0$0$-4.0M
Net Profit$-1.0M$-5.0M$-1.0M$-1.0M$-4.0M
EPS$-0.01$-0.08$-0.01$-0.01$-0.01
Op Margin—————

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$5.0M$0$0$0$0
Total Liabilities$2.0M$3.0M$3.0M$2.0M$2.0M
Cash$0$0$0$0$0
Borrowings$0$1.0M$1.0M$0$0

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$0$0$0$0$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.37
FCF Yield-2.21%
Quick Ratio0.06
Interest Coverage-19.90
Return 1Y-87.50%
Return 3Y-97.78%
Return 5Y—

Ownership

Insiders Held85.19%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CHNXFChitogenX Inc. $0.01 +0.00% -0.23 $627628 0.00%
IPIXInnovation Pharmaceuticals Inc. $0.00 — -0.32 $1.04M 0.00%
LFCOFLift & Co. Corp. $0.00 — -0.01 $63446 0.00%
MDINMedGen, Inc. $0.00 — -600.00 $90309 0.00%
NBIONascent Biotech, Inc. $0.00 — -0.04 $103330 0.00%

About Actavia Life Sciences, Inc.

Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma. Additionally, the company is engaged in formulating small molecule drug candidates, with a particular emphasis on addressing acute myeloid leukemia. Established in 2013, its corporate headquarters are situated in New York, NY.

Actavia Life Sciences, Inc. (RASP) stock trades at $0.00 with a market capitalization of $385906. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.06, reflecting a net loss over the last twelve months, a negative price-to-book of -0.15, reflecting negative shareholders' equity, price-to-sales of 0.00.

On profitability, Actavia Life Sciences, Inc. generates a return on equity (ROE) of 200.00%, above the typical market range of roughly 12-15%, return on capital employed of 216.68%.

Official website: www.rasna.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.